Endocrine and Neuroendocrine Tumor Program

Close up of microscopic slide of endocrine cancer cells

The Endocrine and Neuroendocrine Tumor Program offers a multidisciplinary, comprehensive approach for the full spectrum of treatment for these unique tumors.

Our team of endocrine surgeons, surgical oncologists, endocrinologists, medical oncologists, radiation oncologists, radiologists, advanced practice nurses, nurse navigators, social workers, and genetic counselors collaborate to ensure that each patient is cared for with an individualized approach.

To request an appointment, call 844-CANCERNJ  |  Find a Clinical Trial


What are Endocrine and Neuroendocrine Tumors?

Endocrine and neuroendocrine tumors develop from hormone-producing cells, affecting glands like the thyroid, pancreas, and adrenal glands. These tumors may be benign or malignant, varying in behavior and treatment needs. Risk factors include genetic conditions (e.g., multiple endocrine neoplasia types 1 and 2), family history, smoking, and environmental exposures, though early diagnosis and personalized care are always key to successful outcomes.

With years of experience, our experts specialize in the treatment of:

  • Thyroid cancer, including medullary thyroid cancer
  • Parathyroid tumors
  • Adrenal tumors and hormone-producing adrenal tumors
  • Pheochromocytoma and paraganglioma
  • Adrenocortical cancer
  • Pancreatic neuroendocrine tumors (PNETs)
  • Carcinoid and neuroendocrine tumors throughout the body
Graphic cartoon of a thyroid

The Latest Diagnostic and Treatment Options

Rutgers Cancer Institute and RWJBarnabas Health offer cutting-edge treatment and diagnostic options for endocrine and neuroendocrine tumors. With access to innovative therapies, personalized care, and the latest clinical trials, patients receive comprehensive, personalized care designed to improve outcomes and support their journey to recovery.

Endocrine Surgical Oncology

The Section of Endocrine Surgery at Rutgers Cancer Institute specializes in the comprehensive surgical treatment of thyroid, parathyroid, pancreatic neuroendocrine tumors, and adrenal disorders.

Thyroid Radiofrequency Ablation (RFA)

Thyroid radiofrequency ablation (RFA) is a minimally invasive, non-surgical medical procedure that treats benign lumps on your thyroid known as nodules. 

LUTATHERA®

Lutetium Lu 177 dotatate (also known as LUTATHERA®) is a prescription nuclear medicine approved for treating metastatic neuroendocrine tumors, including pancreatic and small gastrointestinal neuroendocrine tumors.

Additional Treatments

We offer a range of advanced treatment options for these unique tumors, ensuring that each patient receives the most effective, personalized care available.

  • Genetic Testing and Counseling
  • Radiation Therapy
  • Chemotherapy
  • Immunotherapy
  • Advanced treatment options and emerging therapies through clinical trials
  • Support for patients living with cancer through the Survivorship Program

Meet Our Team

Group photo of 4 endocrine oncologists

Our providers meet weekly to coordinate patient care from diagnosis to treatment to follow-up, providing a close, collaborative approach between specialists. Our clinicians also work closely with our scientists on basic, clinical, and translational research activities in an effort to advance our understanding of these unique tumors. With a Designation of Focused Practice in Adult Complex Thyroid and Parathyroid Surgery from the American Board of Surgery, Dr. Laird and Dr. Beninato provide the most comprehensive, advanced treatment options available.


Additional Resources


Articles and Press


Frequently Asked Questions (FAQs)

How common are endocrine tumors?

Benign endocrine tumors, or nodules, of the thyroid, parathyroid, and adrenal glands become more common as we get older. As many as 50% of the population has a thyroid nodule and most of them are benign. Similarly, close to 10% of people may have an adrenal nodule which are also commonly benign. Cancers of the thyroid, parathyroid, and adrenal glands are less common. Evaluation by a dedicated endocrine team can help differentiate between these types of tumors.

How do you diagnose a neuroendocrine or endocrine tumor?

For thyroid and adrenal nodules, many are discovered incidentally on imaging studies done for another reason. Ultrasound is the best test for thyroid nodules, which will determine whether biopsy is necessary. Adrenal nodules are usually evaluated with a CT scan. In addition to imaging studies, blood tests will reveal whether thyroid, parathyroid, or adrenal tumors are hormonally active. A combination of blood tests and imaging studies along with biopsy, if appropriate, will help you and your doctor determine the best course of treatment for you, if necessary.

Can I prevent neuroendocrine and endocrine tumors?

No, most endocrine and neuroendocrine tumors occur sporadically, meaning that they occur without specific cause and are not inherited. Researchers don’t know what causes endocrine and neuroendocrine tumors in most patients. You can understand potential risk factors, for example, if you have an inherited condition such as multiple endocrine neoplasia (MEN).

Can neuroendocrine or endocrine tumors be cured?

This depends on the type of tumor.  The best thing to do is to speak with your doctor and seek care with a doctor who is an expert in this area. There are benign and malignant (cancerous) endocrine and neuroendocrine, including tumors of the thyroid, parathyroid, adrenal glands, pancreas, and gastrointestinal tract. All require different treatments, and cure depends on the tumor type. Research shows that patients do better when treated by a multidisciplinary group of doctors. Our experienced team of surgeons, oncologists, endocrinologists, radiologists, and radiation oncologists work together to individualize patient care.